“Drug-drug interaction? It seems to be complicated, so let’s leave it to the specialists.” That may be current thinking, but will this attitude serve us in the future? New Japanese drug-drug interaction guidelines include drastic changes, such as the application of physiological-based pharmacokinetic (PBPK) models and concrete directions in the descriptions on package inserts. These changes will impact not only pharmacokinetic departments, but other segments of the industry as well, such as regulatory affairs, clinical development and postmarketing, and clinicians and pharmacists who use this information.
This program will provide a basic understanding of drug-drug interaction and the background of new Japanese drug-drug interaction guidelines. The program will also explain the impact of these changes on package inserts. This information can help change “I don’t know” to “I understand!”